ÂÜÀòÂÒÂ×

Richard Buick is an experienced professional in the field of antibody engineering, currently serving as the Chief Scientific Officer, Chief Technical Officer, and Technical Director at Fusion Antibodies plc since April 2002. As a member of the executive management team, Richard oversees all contract research projects and in-house initiatives focused on proteins and antibody engineering. Prior to this role, Richard worked as a Senior Research Scientist, where contributions included the introduction of antibody engineering services and the development of techniques such as chimerization and CDR-grafting. Earlier experience includes a position as a Research Scientist at Randox, where Richard produced several recombinant proteins in E. coli. Richard holds a PhD in Antibody Engineering and a BSc (Honours) in Genetics from Queen's University Belfast.